GBA1 and Parkinson disease: The lack of a consistent phenotype of PD or LBD in patients with GBA1 mutations, viewed as one argument against a loss-of-function mechanism, may simply indicate the complexity of multifactorial disease in which other factors interact with both GBA1 and alpha-synuclein to produce the pathologic findings and clinical symptoms of disease.